Early diagnosis of prostate cancer

G. L. Andriole, W. J. Catalona

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Approximately 50 per cent of patients with carcinoma of the prostate have either advanced local disease or metastases at the time of diagnosis. To achieve earlier diagnosis of prostate cancer in its localized, most treatable stages, it will be necessary to develop safe, cost-effective screening tests with sufficiently high sensitivity and specificity rates. To date, no single test fulfills these criteria, although advances in the measurement of serologic markers of prostate cancer such as prostate-specific antigen, fine-needle aspiration cytology of the prostate, and transrectal prostatic ultrasonography are being widely investigated as potential screening tests.

Original languageEnglish
Pages (from-to)657-661
Number of pages5
JournalUrologic Clinics of North America
Issue number4
StatePublished - 1987


Dive into the research topics of 'Early diagnosis of prostate cancer'. Together they form a unique fingerprint.

Cite this